JBA AI Secures FDA Recognition for Software as a Medical Device (SaMD)
June 9, 2025
Regulatory Milestone Validates JBA AI’s Clinical-Grade Software for Advanced Diagnostic Support
Regulatory Milestone Validates JBA AI’s Clinical-Grade Software for Advanced Diagnostic Support
A Medtronic (NYSE: MDT)+
official announced on social media that the company received CE mark for its VitalFlow system within its Cardiac Surgery portfolio.